hydroxychloroquine living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study

	COVID 19 hospitalized
	COVID 19 hospitalized	COVID 19 all comers	COVID-19 mild to moderate	COVID-19 severe or critically
hydroxychloroquine	Magagnoli ... Arshad ... Fontana OAHU-COVID19 IRCT20200428047228N1 // U07 Singh Geleris Chen CCAP-1 HYCOVID Gonzalez ... Novales NO COVID-19 ... Duke university HCQ HAHPS RECOVERY Kalligeros ARCHAIC -hydroxychloroquine PROTECT A ORCHID Paccoud Belgian Collaborative Group on COVID-19 Duke University hydroxychloroquine/azithromycine Sbidian ... Abd-Elsalam PROTECT B Tang SOLIDARITY ... Cravedi TEACH	Gautret et al. ChiCTR2000030054-HCQ ... IRCT20150808023559N20 IRCT20150808023559N20 NCT04376814-Group A NCT04376814-Group A NOR-Solidarity ...	Zhaowei Chen Min Coalition Covid-19 Brazil I ... Dubee NCT04333654 Kamran HC-nCoV ... FACCT Trial	Sarhan Yu REMAP-CAP-HCQ HYDRA ... Mahevas Sarhan

5560	BCN PEP-CoV-2-Study 2 (Mitja Lancet-preprint), 2020	2	1	2	excluded
5564	Kanran M, 2020	2	1	0	excluded		risk of bias not avaialble
5776	Alberici, 2020	2	13	4	excluded	not a RCT	high risk of bias
5864	HYDRA, 2020	2	1	0	excluded		risk of bias not avaialble
6032	Mohana, 2020	2	12	0	excluded	not a RCT	risk of bias not avaialble